Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for depressive patients undergoing total hip arthroplasty
ChiCTR2100054655Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD), postoperative pain and hip osteoarthritis comparing Duloxetine with Placebo (2 arms). Primary endpoint: Pain with ambulation. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)postoperative painhip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2100054655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054655.